Overview

Relative Bioavailability Study

Status:
Completed

Trial end date:
2012-11-01

Target enrollment:

Participant gender:

Summary

This is a BA study comparing the bioavailability of two new capsule formulations and one solution formulation to the isethionate capsule used in phase 1 and 2 trials in healthy volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Treatments:

Palbociclib